Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells

Journal of Cellular Physiology

Volumn 183, Issue 1, 2000, Pages 28-36

  Mujumdar, Vibhas S ^a   Hayden, Melvin R ^a   Tyagi, Suresh C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CALCIUM;

ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL PROLIFERATION; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; CALCIUM; CELLS, CULTURED; COLLAGEN; FELODIPINE; FLUORESCENT DYES; FURA-2; GLUTATHIONE; HOMOCYSTEINE; HOMOCYSTINE; KINETICS; MUSCLE, SMOOTH, VASCULAR; NEOMYCIN; NG-NITROARGININE METHYL ESTER; PRAVASTATIN; RATS; SECOND MESSENGER SYSTEMS; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; THAPSIGARGIN;

ANIMALIA;

EID: 0034009713     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O     Document Type: Article

References (37)

1. Cohn JN, Ziesche SM, Loss LE, Andersen GF. 1995. Effect of felodipine on short-term excercise and neurohormone and long-term mortality in heart failure: results of V-HeFT VII. Circulation 92:I-143.
2. 2+ stores and protein synthesis in human endothelial cells. Cir Res 76:388-395.
3. Grupp I, Im WB, Lee CO, Lee SW, Pecker MS, Schwartz A. 1985. A relation of sodium pump inhibition to positive inotropy at low concentrations of ouabain in rat heart muscle. J Physiol 360:149-160.
4. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT. 1998. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 273:9987-9993.
5. Hollenberg MD. 1994. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108-114.
6. Hori M, Sato H, Fukunami M, Houki N. 1993. Pathophysiology of cytoskeleton and ECM in failing myocardium. Jpn J Clin Med 51:1191-1197.
7. Iwamoto T, Harada K, Nakajima F, Sukamoto T. 1992. effect of ouabain om muscle tension and intracellular calcium level in guinea-pig aorta. Eur J Pharmacol 224:71-76.
8. Jourdheuil-Rahmani D, Rolland PH, Rosset E, Branchereau A, Garcon D. 1997. Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors, Cardiovas Res, 34:597-602.
9. Jukema JW, Bruschke AV, van Boven AJ, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, van Rappard FM, Lie KI. 1995. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The regression growth evaluation statin study (REGRESS). Circulation 91:2528-2540.
10. 2+] with fluorescent indicators. Meth Cell Biol 40:155-181.
11. Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. 1994. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem 269:21505-21511.
12. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227:680-685.
13. Magott M. 1998. Homocysteine as a nonlipid factor in the pathogenesis of atherosclerosis. Post Hig Med Doswiad, 52:259-267.
14. Majors A, Ehrhart LA, Pezacka EH. 1997. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by SMC. Arterioscler Thromb Vasc Biol, 17:2074-2081.
15. McCully KS. 1969. Vascular pathology of homocysteinemia. Am J Pathiol 56:111-128.
16. Nygard O, Nordrehaug JE, Refsum H, Ureland PM, Farstad M, Vollset SE. 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 337:230-236.
17. Puri PL, Avantaggiati A, Burgio VL, Chirillo P, Collepardo D, Natoli G, Balsano C, Leverero M. 1995. Reactive oxygen intermediates are involved in the intracellular transduction of angiotenin II signal in C2C12 cells. Ann NY Acad Sci 752:395-405.
18. Rizvi MA, Myers PR. 1997. Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J Mol Cell Cardiol 29:1779-1789.
19. Rodgers GM, Kane WH. 1986. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909-1916.
20. Rolland PH, Friggi A, Barlaitier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringheli O. 1995. Hyperhomocysteinemia-induced vascular damae in the minipig. Circulation 91:1161-1174.
21. Suarez J, Chagoya de Sanchez V. 1997. Inhibition of S-adenosyl-l-homocysteine hydrolase by adrenaline in isolated guinea pig papillary muscles. Intern J Biochem Cell Biol 29:1279-1284.
22. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. 1997. Hyperhomocysteinemia is associated with impaired endothelial-dependent vasodilation in humans. Circulation 95:1119-1121.
23. Touyz RM, Schiffrin EL. 1997. Angiotensin II regulates vascular smooth muscle cell pH, contraction and growth via tyrosin kinase dependent signaling pathways. Hypertension 30:222-229.
24. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Harber E, Schlegel R, Lee ME. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-6373.
25. Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, Haber E, Chang TH, Schlegel R, Lee ME. 1996. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest97:146-153.
26. Tyagi SC. 1996. Role of oxidative mixed disulfide formation in elastase-serine proteinases inhibitor (serpin) complex. Biochem Cell Biol 74:391-401.
27. Tvagi SC. 1998. Homocysteine redox receptor and ECM remodeling in vascular cells. Am J Physiol 274:C396-C405.
28. Tyagi SC, Kumar SG, Glover G. 1995a. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 58:360-371.
29. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. 1995b. Proteinases and restenosis in human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116:43-57.
30. Tyagi SC, Kumar S, Katwa L. 1997. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J. Mol Cell. Cardiol 29:391-404.
31. Tyagi SC, Smiley LM, Mujumdar VM, Clonts B, Parker JL. 1998. Reduction-oxidation (redox) receptor and vascular tissue level of homocysteine in human coronary atherosclerotic lesions and role of ECM remodeling and vascular tone. Mol Cell Biochem 181: 107-116.
32. Upchurch GR, Jr, Welch GN, Loscalzo J. 1996. Homocysteine, EDRF, and endothelial function. J Nutr 126:1290S-1294S.
33. Upchurch GR Jr., Welch GN, Fabian AJ, Pigazzi A, Keaney JF Jr., Loscalzo J. 1997. Stimulation of endothelial nitric oxide production by homocysteine. Atherosclerosis, 132:177-185.
34. Varga Z, Kovacs EM, Paragh G, Jacob MP, Robert L, Fulop T. 1988. Effect of elastin peptides and N-formyl-methionyl-leucyl phenylalanine on cytosolic free calcium in polymorphonuclear leukocytes of healthy middle-aged and elderly subjects. Clin Biochem 21:127-130.
35. van der Molen EF, van den Heuvel LP, Poele Pothoff LP, Monnens IA, Eskes TK, Blom HJ. 1996. The effect of folic acid on the homocysteine metabolism in human umbilical vein endothelial cells. Eur J Clin Invest 26:304-309.
36. Wang W, Hayama N, Robinson TV, Kramer RE, Schneider EG. 1992. Effect of osmolality on cytosolic free calcium and aldosterone secretion. Am J Physiol 262:E68-75.
37. Wickham NWR, Vercellotti GM, Moldow CF, Visser MR, Jacob HS. 1988. Measurements of intracellular calcium concentration in intact monolayers of human endothelial cells. J Lab Clin Med 112: 157-167.